Container Top
Search

Events Calendar

EVENT SEARCH:

In This Section


Most Read Stories


Blogs:


First Bell - On Education:
No City of Akron basketball tonight

Pets:
Pet telethon re-airs

The Heldenfiles:
Chipmunks "Squeakquel" on DVD/BD March 30

Akron Zips:
Late surge gives Zips ugly road win

Tribe Matters:
Blogmail response on Hafner

Cleveland Browns:
Stallworth's contract terminated

Balanced Ledger:
QB in Browns future: another mock draft

Kent State Sports:
KSU Notes – February 9

Cleveland Cavaliers:
NBA Power Rankings from Around the Internet

Buckeye Blogging:
Buckeyes grab 18 players on signing day

Varsity Letters:
Garfield at Buchtel basketball

All Da King's Men:
Palin At The Tea Party Convention

Blog of Mass Destruction:
Republican Pre-Conditions

Akron Law Café:
Law, Love and Chocolate

Car Chase:
Collector Car Hobby Loses One of the Best—Jim Roll

Let's Talk Real Estate:
Decisions Decisions: Credit Cards or Your Mortgage?

Ohio Travels with Betty:
Loucile is looking for a Lake Erie getaway in June for three kids, ages 1, 3, and 5.

Sound Check:
Talk of the Town – Top entertainment picks for the weekend

HRLite House:
OFCCP Report

Akron Gamer:
Makers of 'Castle Crashers' unveil 'BattleBlock Theater'

See Jane Style:
Do IT this week: Layering

Enrollment in heart-disease study halted

Officials investigate whether participants informed of risk in the largest alternative medicine program

The largest alternative medicine study the government has ever launched has stopped enrolling people while officials investigate whether participants were fully informed of the risks and are being adequately protected, the Associated Press has learned.

More than 1,500 heart-attack survivors are involved in the research, which tests a controversial treatment called chelation. It is mainly used to treat lead poisoning.

At least two people have died, although the Miami doctor leading the study said the deaths were not a direct result of the treatments. He said he doesn't know exactly how many deaths have occurred.

He also acknowledged that some doctors who had been involved in the study have been disciplined by state boards or have criminal records and have been asked to drop out.

''We think we have a safe and ethical trial and we're protecting our patients,'' said the leader, Dr. Gervasio Lamas of the University of Miami.

Federal officials confirmed their probe of the $30 million study Thursday. Those directing the research, conducted at 100 sites around the United States and Canada, voluntarily stopped enrolling patients earlier this month, after the investigation was launched.

The research was designed to test high doses of vitamin and mineral supplements and chelation, which has not been proved effective for heart disease. Chelation involves intravenous doses of a drug, in this case disodium EDTA, that proponents claim will bind to calcium built up in artery walls and help flush it from the body.

Conventional treatments for heart disease include medicines, surgery and artery-clearing angioplasty.

When the study was approved in 2002, federal officials said many heart patients were exploring chelation therapy, and the research would give answers about whether the treatment was safe and effective.

A similar philosophy was behind an effort to test chelation on autistic children. The government, however, recently scrapped that plan, citing safety concerns as one reason.

The heart disease study was based on misrepresentations about safety and effectiveness and ''should never have been approved,'' said Dr. Kimball Atwood, an anesthesiologist in suburban Boston and an assistant clinical professor at Tufts University.

He and several others sent a complaint about the heart study to the federal research protection agency, and recently published a lengthy report detailing alleged problems.

The largest alternative medicine study the government has ever launched has stopped enrolling people while officials investigate whether participants were fully informed of the risks and are being adequately protected, the Associated Press has learned.

Get the full article here.


Story tools

Email  Email   Print  Print   Save  Save   Reprint  Reprint   Popular  Most Popular   Reprint  Subscribe

Share this story

AddThis Social Bookmark Button














Most Commented Stories